Live Chat

Trade AstraZeneca AZN

Sell
 Buy

AstraZeneca live chart

5m 15m 30m 1h 4h 1d 1w

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

Info

Spread

73.63

Spread (%)

0.6186 %

Leverage

1:10

Overnight Interest Buy

-0.0590 %

Overnight Interest Sell

-0.0299 %

Currency

PNC

Trading Hours

Markets closed

Monday

07:01 - 10:59

Tuesday

07:01-10:59

Tuesday

11:03-15:29

Wednesday

07:01-10:59

Wednesday

11:03-15:29

Thursday

07:01-10:59

Thursday

11:03-15:29

Friday

07:01-10:59

Friday

11:03-15:29

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

167934820352

Shares Outstanding

1550300032

Earnings Date (Next)

0000-00-00

Div Yield

Ex-Dividend Date

2024-08-08

Forward annual dividend rate

2.34

Forward annual dividend yield

0.0231

EPS

3.18

Learn more about this instrument

AstraZeneca AstraZeneca PLC
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.

Related Instruments

Asset
Sell
Buy
Change (%)

Trade Now

Trade Now

Trade Now

Trade Now
View all instruments

Latest news

Stay updated with the latest financial news from around the world.

Wednesday, 6 November 2024

U.S. presidential election market volatility drives Bitcoin prices to reach a historic high

Stock market rally

Tuesday, 5 November 2024

US Election Results Trigger Stock Gains Across Europe, Asia, and US

US Election Trump's victory

Tuesday, 5 November 2024

Trump Victory Spurs Market Gains and Economic Shift Expectations

Tuesday, 5 November 2024

US election: bitcoin price (BTC) surged to new record as Trump leading ahead

Tuesday, 5 November 2024

Stock Market Today: Wall Street Rallies on Election Day Amid Strong Economic Outlook

US Election 2024 Trump

Tuesday, 5 November 2024

Early Election Results Shift Markets as Trump’s Chances Rise

Monday, 4 November 2024

Stock Market Today: S&P 500 Declines as Investors Brace for US Election

Monday, 4 November 2024

US election: What will happen to tesla stock if Trump wins?

See all news
Trustpilot
Live Chat